Further Evidence For Ultraviolet Light Induction Of CDKN2(p16INK4) Mutations In Sporadic Melanoma In Vivo
Rudolf Herbst(Helios Klinikum Erfurt), Webster K. Cavenee(University of California San Diego), Alexander Kapp(Medizinische Hochschule Hannover), Karen C. Arden(Ludwig Cancer Research), Frank Matiaske(Medizinische Hochschule Hannover), Susanne Mommert(Medizinische Hochschule Hannover), Jürgen Weiß(Medizinische Hochschule Hannover), Ralf Gutzmer(University Hospitals of the Ruhr-University of Bochum)
Cited by 21
Related Papers
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
|The Lancet|2012|3k
Malignant astrocytic glioma: genetics, biology, and paths to treatment
|Genes & Development|2007|2.3k
The WHO Classification of Tumors of the Nervous System
|Journal of Neuropathology & Experimental Neurology|2002|2k
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
|New England Journal of Medicine|2018|1.9k